Back to News
Market Impact: 0.3

BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update

Source: Nasdaq

Corporate EarningsHealthcare & BiotechCompany Fundamentals

BioNTech reported Q3 2026 revenue of €1,289.2 million, down from €1,518.9 million a year earlier (about 15%). Net profit was €184.5 million, versus a net loss of €28.7 million in the prior-year quarter. The article text ends mid-sentence, so no further results or outlook are available.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

0.10

Ticker Sentiment

BNTX0.45

More News

From AllMind Research

Browse all research